Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 6,190 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Medication Group Clear all

Conditions: Oral Mucositis
Interventions: RRx-001, Cisplatin for injection, Radiation Therapy; Drug · Radiation
Lead sponsor: EpicentRx, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 12
States / cities: Santa Monica, California • Denver, Colorado • Washington D.C., District of Columbia + 9 more

Conditions: Hepatic Impairment, Healthy, Hepatic Insufficiency, Healthy Adults
Interventions: Atirmociclib; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Miami Lakes, Florida • Orlando, Florida • Tampa, Florida

Conditions: Familial Hypoalphalipoproteinemia
Interventions: CER-001, Placebo; Drug
Lead sponsor: Cerenis Therapeutics, SA; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Attention Deficit Hyperactivity Disorder, ADHD
Interventions: fMRI scans, Atomoxetine arm, Methylphenidate arm; Other · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 7 Years to 17 Years
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Prostate Cancer
Interventions: Intensity-Modulated Radiation Therapy (IMRT), Docetaxel+IMRT; Radiation · Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2023
U.S. locations: 2
States / cities: Portland, Oregon

Conditions: Depression / Major Depressive Disorder, Food Insecurity
Interventions: Medically Tailored, Home-delivered Groceries, Active Comparison Group: Monthly Grocery Gift Card; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Worcester, Massachusetts

Conditions: Diabetes
Interventions: Promotora-led Intervention, Metformin Therapy, Usual Care; Behavioral · Drug · Other
Lead sponsor: Temple University; Other
Eligibility: 20 Years to 75 Years · Female only
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes
Interventions: Home Visitiation, Education; Behavioral
Lead sponsor: Delta Health Alliance; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Leland, Mississippi

Conditions: Spinal Fusion, Adolescent Idiopathic Scoliosis
Interventions: Dexmedetomidine, Normal Saline; Drug
Lead sponsor: Nichole Doyle; Other
Eligibility: 10 Years to 21 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Sport Injury, Attention-deficit/Hyperactivity Disorder
Interventions: Soccer Heading; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 26 Years
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Rheumatoid Arthritis
Interventions: ABT-122, Placebo; Biological
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 4
States / cities: Lenexa, Kansas • Raleigh, North Carolina • Duncansville, Pennsylvania + 1 more

Conditions: Gastroesophageal Reflux, Patient Activation
Interventions: Use of mHealth Question Prompt List app; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Gynecologic Cancer
Interventions: Lidocaine Bolus Infusion, QL block, Saline Bolus Infusion, Simulated QL block; Drug · Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 69 Years · Female only
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Vertebral Compression Fracture, Facet Joint Pain
Interventions: Radiofrequency ablation of the medial branch nerves, Non-steroidal anti-inflammatory drugs, Bisphosphonates, Acetaminophen, Physical therapy, Opioids; Procedure · Drug · Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Davis, California

Conditions: Hypertension
Interventions: CHW Intervention, Wait List Control Group; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Opiate-Related Disorders, Opiate Use Disorder, Opioid
Interventions: MedSMA℞T Mobile; Behavioral
Lead sponsor: Olufunmilola Abraham; Other
Eligibility: 12 Years and older
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 3
States / cities: Rockford, Illinois • Madison, Wisconsin

Conditions: Healthy Young Volunteers, Healthy Elderly Volunteers
Interventions: AZD3293, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Tuberculosis
Interventions: SQ109; Drug
Lead sponsor: Sequella, Inc.; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: Rotator Cuff Tear
Interventions: 0.5% bupivacaine, Normal Saline; Drug
Lead sponsor: Orlando Health, Inc.; Other
Eligibility: 18 Years to 90 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Health Behavior Modification Using Mindfulness
Interventions: Mindful Awareness Program, Health Promotion Program; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Mild Traumatic Brain Injury, Posttraumatic Stress Disorders, Depression
Interventions: Multifamily Group for mTBI for Couples, Group Health Education (GHE); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 249 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 3
States / cities: Baltimore, Maryland • New York, New York • The Bronx, New York

Conditions: Diabetes Mellitus, Type 2, Hypertension
Interventions: EXTEND Plus, EXTEND; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 30 Years to 75 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Bone Graft, Tooth Extraction
Interventions: Dexamethasone 4mg/ml solution; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 89 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Multiple Chronic Conditions
Interventions: mHealth intervention, mHealth Plus; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Lincoln, Nebraska

Search by objective public record fields.

Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers

A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease

CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases

Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach

Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer

The Medically Tailored Groceries and Mental Health Study

Intervention to Promote Weight Loss in Latinas At-risk for Diabetes

Pilot of Home Visitation Services for Patients With a Diabetes Diagnosis

Low Dose Dexmedetomidine as a Postoperative Pain Adjunct

Effects of Subconcussive Head Impacts on Neural Integrity and Function in ADHD

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis

Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux Disease

Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone

Radiofrequency Ablation: Treatment for Posterior Element Pain From Vertebral Compression Fractures

Project IMPACT: CHW Intervention

MedSMA℞T Mobile ED

A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects

Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers

Post-Op Rotator Cuff Pain Study With Subacromial Bupivacaine Infusion

Promoting Adherence to Anti-Hypertensive Medications and Lifestyle Guidelines Through Mindfulness Practice

Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI

Expanding Technology-Enabled Nurse Delivered Chronic Disease Care

Ridge Preservation With FDBA (Freeze Dried Bone Allograft) Using Dexamethasone vs. Saline

Self-Management Interventions Using Mobile Health for the Multimorbid